Michael Schepke

Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase

Jonel Trebicka, Martin Hennenberg, Wim Laleman et al. · Hepatology · 2007 · 300 citations · Full text

Medicine, Biochemistry, Pharmacology +17

Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy

Tilman Sauerbruch, Martin Mengel, Matthias Dollinger et al. · Gastroenterology · 2015 · 254 citations · Full text

Medicine, Pharmacotherapy, Surgery +17

Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis†

Michael Schepke, G. Kleber, Dieter Nürnberg et al. · Hepatology · 2004 · 225 citations

Medicine, Pharmacotherapy, Surgery +14

Comparison of Meld, Child-Pugh, and Emory Model for The Prediction of Survival in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunting

Michael Schepke, Felix Roth, Rolf Fimmers et al. · The American Journal of Gastroenterology · 2003 · 178 citations

Medicine, Internal Medicine, Hepatology +16

Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension

Michael Schepke, Erwin Biecker, Peter Schiedermaier et al. · Gastroenterology · 2001 · 143 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16